{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:13:47Z","timestamp":1782371627159,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR190078"],"award-info":[{"award-number":["RR190078"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CCSG P30 CA016672"],"award-info":[{"award-number":["CCSG P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205039\/Z\/16\/Z"],"award-info":[{"award-number":["205039\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["SAC150061"],"award-info":[{"award-number":["SAC150061"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RP160674"],"award-info":[{"award-number":["RP160674"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["P30 AR069589"],"award-info":[{"award-number":["P30 AR069589"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.xjidi.2024.100272","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T21:26:48Z","timestamp":1711142808000},"page":"100272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antihypertensive Medications and Risk of Melanoma and Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-5937","authenticated-orcid":false,"given":"Olivia G.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-7936","authenticated-orcid":false,"given":"Matthew","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-2155","authenticated-orcid":false,"given":"Cassandra","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-8298","authenticated-orcid":false,"given":"Kevin T.","family":"Nead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-0204","authenticated-orcid":false,"given":"Candice L.","family":"Hinkston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-2767","authenticated-orcid":false,"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-7441","authenticated-orcid":false,"given":"Sinead M.","family":"Langan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-8085","authenticated-orcid":false,"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-2282","authenticated-orcid":false,"given":"Mackenzie R.","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2024.100272_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2020.08.025","article-title":"Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: a population-based case-control study","volume":"84","author":"Adalsteinsson","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(02)00157-0","article-title":"Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study","volume":"39","author":"Beiderbeck-Noll","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/cmi.cmi_36_21","article-title":"Long-term hydrochlorothiazide use and risk of cutaneous neoplasms","author":"Bright","year":"2021","journal-title":"Curr Med Issues"},{"key":"10.1016\/j.xjidi.2024.100272_bib4","article-title":"Propranolol reduces cancer risk: a population-based cohort study","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.xjidi.2024.100272_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","article-title":"VATTC Trial. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial","volume":"100","author":"Christian","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.xjidi.2024.100272_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bcpt.13463","article-title":"Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: a population-based case-control study","volume":"127","author":"Daniels","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.xjidi.2024.100272_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2012.11081.x","article-title":"Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study","volume":"167","author":"de Vries","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib9","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Chapter 10: analysing data and undertaking meta-analyses","author":"Deeks","year":"2023"},{"key":"10.1016\/j.xjidi.2024.100272_bib10","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1503\/cmaj.201971","article-title":"Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study","volume":"193","author":"Drucker","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.xjidi.2024.100272_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/11592780-000000000-00000","article-title":"Drug-induced photosensitivity: culprit drugs, management and prevention","volume":"34","author":"Drucker","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib12","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/jid.2012.227","article-title":"Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial","volume":"132","author":"Dyer","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkab009","article-title":"Risk of nonmelanoma skin cancer in association with use of hydrochlorothiazide-containing products in the United States","volume":"5","author":"Eworuke","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.xjidi.2024.100272_bib15","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark","volume":"92","author":"Friis","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00045415-200207000-00008","article-title":"Adverse dermatologic effects of cardiovascular drug therapy: part I","volume":"10","author":"Frishman","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.xjidi.2024.100272_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5414\/CP202842","article-title":"Angiotensin receptor blockers and the risk of cancer: data mining of a spontaneous reporting database and a claims database","volume":"55","author":"Fujimoto","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.xjidi.2024.100272_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1574886316666211103164412","article-title":"Is there a link between non melanoma skin cancer and hydrochlorothiazide?","volume":"17","author":"Gallelli","year":"2022","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.12.003","article-title":"Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis","volume":"122","author":"Gandini","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.xjidi.2024.100272_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ije\/dyac223","article-title":"Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study","volume":"52","author":"Ghiasvand","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.xjidi.2024.100272_bib21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pds.5266","article-title":"Hydrochlorothiazide and risk of melanoma subtypes","volume":"30","author":"Habel","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists","volume":"16","author":"Hole","year":"1998","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.xjidi.2024.100272_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.306.6878.609","article-title":"Incidence of and mortality from cancer in hypertensive patients","volume":"306","author":"Hole","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2024.100272_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6604686","article-title":"Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study","volume":"99","author":"Jensen","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib25","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","article-title":"Photosensitizing medication use and risk of skin cancer","volume":"19","author":"Kaae","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.xjidi.2024.100272_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/ced.14520","article-title":"Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data","volume":"46","author":"Kim","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.canep.2009.10.005","article-title":"Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"33","author":"Koomen","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.xjidi.2024.100272_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5414\/CP203769","article-title":"Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: a case\/non-case study","volume":"59","author":"Lecaros-Astorga","year":"2021","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.xjidi.2024.100272_bib29","first-page":"2910","article-title":"Association between use of hydrochlorothiazide and nonmelanoma skin cancer: common data model cohort study in Asian population","volume":"9","author":"Lee","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pds.5295","article-title":"Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain","volume":"30","author":"Le\u00f3n-Mu\u00f1oz","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2024.100272_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(01)05704-X","article-title":"Relation between drug treatment and cancer in hypertensives in the Swedish trial in old patients with hypertension 2: a 5-year, prospective, randomized, controlled trial","volume":"358","author":"Lindholm","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2024.100272_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-14-0251","article-title":"Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort","volume":"23","author":"McDonald","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.xjidi.2024.100272_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/bcp.14245","article-title":"Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies","volume":"86","author":"Morales","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xjidi.2024.100272_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-016-0487-9","article-title":"Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study","volume":"40","author":"Nardone","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","article-title":"Cancer risk in users of calcium channel blockers","volume":"29","author":"Olsen","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.xjidi.2024.100272_bib38","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Chapter 13: assessing risk of bias due to missing results in a synthesis. Cochrane Handbook for Systematic Reviews of Interventions version 60","author":"Page","year":"2023"},{"key":"10.1016\/j.xjidi.2024.100272_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","article-title":"Calcium-channel blockade and incidence of cancer in aged populations","volume":"348","author":"Pahor","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2024.100272_bib40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3904\/kjim.2019.218","article-title":"Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea","volume":"35","author":"Park","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","article-title":"Association of hydrochlorothiazide use and risk of malignant melanoma","volume":"178","author":"Potteg\u00e5rd","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41416-019-0613-4","article-title":"Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study","volume":"121","author":"Potteg\u00e5rd","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib44","first-page":"27","article-title":"Mechanisms of photosensitization induced by drugs: a general survey","volume":"41","author":"Quintero","year":"2000","journal-title":"Ars Pharm"},{"key":"10.1016\/j.xjidi.2024.100272_bib45","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/jid.2013.33","article-title":"Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study","volume":"133","author":"Robinson","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer","volume":"279","author":"Rosenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.xjidi.2024.100272_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40264-020-01015-1","article-title":"Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer","volume":"44","author":"Rouette","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib48","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.ejca.2010.04.024","article-title":"High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study","volume":"46","author":"Ruiter","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9149(99)00113-7","article-title":"Verapamil and risk of cancer in patients with coronary artery disease. DAVIT study group. Danish verapamil infarction trial","volume":"83","author":"Sajadieh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.xjidi.2024.100272_bib50","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jdv.12921","article-title":"Use of antihypertensive drugs and risk of skin cancer","volume":"29","author":"Schmidt","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2024.100272_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bjd.19880","article-title":"Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group [published correction appears in Br J Dermatol 2022;187:1060\u20131070]","volume":"185","author":"Schneider","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0781.1997.tb00100.x","article-title":"Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: investigations in hairless mice","volume":"13","author":"Selvaag","year":"1997","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.xjidi.2024.100272_bib54","author":"Soe"},{"key":"10.1016\/j.xjidi.2024.100272_bib55","series-title":"Stata statistical software","year":"2019"},{"key":"10.1016\/j.xjidi.2024.100272_bib56","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2024.100272_bib57","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.xjidi.2024.100272_bib58","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/bjd.16713","article-title":"Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma","volume":"179","author":"Su","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.4384","article-title":"Use of antihypertensive drugs and risk of keratinocyte carcinoma: a meta-analysis of observational studies","volume":"27","author":"Tang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40264-017-0599-x","article-title":"Use of antihypertensive drugs and risk of malignant melanoma: a meta-analysis of observational studies","volume":"41","author":"Tang","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.xjidi.2024.100272_bib61","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1111\/ijd.15900","article-title":"Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population","volume":"61","author":"Tiba","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib63","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1186\/s12889-022-13705-9","article-title":"Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer","volume":"22","author":"VanWormer","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.xjidi.2024.100272_bib65","author":"Wells GA Shea"},{"key":"10.1016\/j.xjidi.2024.100272_bib66","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.1996.216","article-title":"Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors","volume":"73","author":"Westerdahl","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.xjidi.2024.100272_bib67","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2013.35","article-title":"Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial","volume":"133","author":"Xiong","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib68","first-page":"12","article-title":"Photosensitivity: light, sun and pharmacy","volume":"16","author":"Zammit","year":"2010","journal-title":"J\u00a0Malta Coll Pharm Pract"},{"key":"10.1016\/j.xjidi.2024.100272_bib69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2020.08.025","article-title":"Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: a population-based case-control study","volume":"84","author":"Adalsteinsson","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100272_bib70","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","article-title":"Photosensitizing medication use and risk of skin cancer","volume":"19","author":"Kaae","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.xjidi.2024.100272_bib71","first-page":"2910","article-title":"Association between use of hydrochlorothiazide and nonmelanoma skin cancer: common data model cohort study in Asian population","volume":"9","author":"Lee","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib72","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/bcp.14245","article-title":"Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies","volume":"86","author":"Morales","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xjidi.2024.100272_bib73","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","article-title":"Association of hydrochlorothiazide use and risk of malignant melanoma","volume":"178","author":"Potteg\u00e5rd","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.xjidi.2024.100272_bib74","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.ejca.2010.04.024","article-title":"High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study","volume":"46","author":"Ruiter","year":"2010","journal-title":"Eur J Cancer"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:43:41Z","timestamp":1778928221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026724000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2667026724000195"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100272","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive Medications and Risk of Melanoma and Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100272"}}